Literature DB >> 24062170

Management of insomnia and long-term use of sedative-hypnotic drugs in older patients.

Jacqueline M McMillan, Elizabeth Aitken, Jayna M Holroyd-Leduc.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24062170      PMCID: PMC3832558          DOI: 10.1503/cmaj.130025

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  38 in total

1.  Insomnia and hypnotic use, recorded in the minimum data set, as predictors of falls and hip fractures in Michigan nursing homes.

Authors:  Alon Y Avidan; Brant E Fries; Mary L James; Kristina L Szafara; Glenn T Wright; Ronald D Chervin
Journal:  J Am Geriatr Soc       Date:  2005-06       Impact factor: 5.562

2.  Zopiclone versus triazolam in insomniac geriatric patients: a specific increase in delta sleep with zopiclone.

Authors:  J Mouret; D Ruel; F Maillard; M Bianchi
Journal:  Int Clin Psychopharmacol       Date:  1990-04       Impact factor: 1.659

3.  Efficacy and safety of doxepin 6 mg in a four-week outpatient trial of elderly adults with chronic primary insomnia.

Authors:  Alan Lankford; Roberta Rogowski; Beal Essink; Elizabeth Ludington; H Heith Durrence; Thomas Roth
Journal:  Sleep Med       Date:  2011-12-24       Impact factor: 3.492

4.  Outcome of new benzodiazepine prescriptions to older adults in primary care.

Authors:  Gregory E Simon; Evette J Ludman
Journal:  Gen Hosp Psychiatry       Date:  2006 Sep-Oct       Impact factor: 3.238

5.  Does melatonin improve sleep in older people? A randomised crossover trial.

Authors:  Jonathan J Baskett; Joanna B Broad; Philip C Wood; John R Duncan; Megan J Pledger; Judie English; Josephine Arendt
Journal:  Age Ageing       Date:  2003-03       Impact factor: 10.668

6.  One-time counselling decreases the use of benzodiazepines and related drugs among community-dwelling older persons.

Authors:  Maritta Salonoja; Marika Salminen; Pertti Aarnio; Tero Vahlberg; Sirkka-Liisa Kivelä
Journal:  Age Ageing       Date:  2010-01-20       Impact factor: 10.668

7.  Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia.

Authors:  M Roger; P Attali; J P Coquelin
Journal:  Clin Ther       Date:  1993 Jan-Feb       Impact factor: 3.393

8.  Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial.

Authors:  Lucie Baillargeon; Philippe Landreville; René Verreault; Jean-Pierre Beauchemin; Jean-Pierre Grégoire; Charles M Morin
Journal:  CMAJ       Date:  2003-11-11       Impact factor: 8.262

9.  Effects of a brief behavioral treatment for late-life insomnia: preliminary findings.

Authors:  Anne Germain; Douglas E Moul; Peter L Franzen; Jean M Miewald; Charles F Reynolds; Timothy H Monk; Daniel J Buysse
Journal:  J Clin Sleep Med       Date:  2006-10-15       Impact factor: 4.062

10.  Is melatonin helpful in stopping the long-term use of hypnotics? A discontinuation trial.

Authors:  Frans H J A Vissers; Paul G Knipschild; Harry F J M Crebolder
Journal:  Pharm World Sci       Date:  2007-07-03
View more
  12 in total

1.  Long-term use of diphenhydramine.

Authors:  H C George Wong
Journal:  CMAJ       Date:  2015-10-06       Impact factor: 8.262

Review 2.  Benzodiazepine Use, Misuse, and Harm at the Population Level in Canada: A Comprehensive Narrative Review of Data and Developments Since 1995.

Authors:  Yoko Murphy; Emily Wilson; Elliot M Goldner; Benedikt Fischer
Journal:  Clin Drug Investig       Date:  2016-07       Impact factor: 2.859

3.  Using Canadian Primary Care Sentinel Surveillance Network data to examine depression in patients with a diagnosis of Parkinson disease: a retrospective cohort study.

Authors:  Kimberly Rose P Singian; Morgan Price; Vicky Bungay; Sabrina T Wong
Journal:  CMAJ Open       Date:  2016-08-08

4.  The Association Between Benzodiazepine Use and Depression Outcomes in Older Veterans.

Authors:  Amanda Leggett; Janet Kavanagh; Kara Zivin; Claire Chiang; Hyungjin M Kim; Helen C Kales
Journal:  J Geriatr Psychiatry Neurol       Date:  2015-08-12       Impact factor: 2.680

Review 5.  Novel class of medications, orexin receptor antagonists, in the treatment of insomnia - critical appraisal of suvorexant.

Authors:  Jessica L Norman; Sarah L Anderson
Journal:  Nat Sci Sleep       Date:  2016-07-14

6.  Using benzodiazepines and Z-drugs for managing primary insomnia in adults in Saudi Arabia: an e-Delphi study to aid the development of clinical guidelines.

Authors:  Ali Dobia; Kath Ryan; Ahmed S BaHammam; Alexander Edwards
Journal:  Sleep Breath       Date:  2019-02-07       Impact factor: 2.816

7.  Non-pharmacological Treatment for Elderly Individuals With Insomnia: A Systematic Review and Network Meta-Analysis.

Authors:  Chan-Young Kwon; Boram Lee; Moon Joo Cheong; Tae-Hun Kim; Bo-Hyoung Jang; Sun Yong Chung; Jong Woo Kim
Journal:  Front Psychiatry       Date:  2021-01-28       Impact factor: 4.157

8.  Pharmacist-led sedative-hypnotic deprescribing in team-based primary care practice.

Authors:  Eric Lui; Kimberly Wintemute; Maria Muraca; Christine Truong; Rita Ha; Albert Kee Buhm Choe; Laura Michell; Joanne Laine-Gossin; Harvey Blankenstein; Stephanie Klein; Dana Mayer; Victor Feder; Michelle Greiver
Journal:  Can Pharm J (Ott)       Date:  2021-06-11

9.  Oriental herbal medicine for insomnia in the elderly with hypertension: A systematic review protocol.

Authors:  Chan-Young Kwon; Boram Lee; Sun-Yong Chung; Jong Woo Kim; Sang-Ho Kim
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

10.  Health-related quality of life in hospitalized older patients with versus without prolonged use of opioid analgesics, benzodiazepines, and z-hypnotics: a cross-sectional study.

Authors:  Socheat Cheng; Tahreem Ghazal Siddiqui; Michael Gossop; Knut Stavem; Espen Saxhaug Kristoffersen; Christofer Lundqvist
Journal:  BMC Geriatr       Date:  2020-10-23       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.